Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
Findings will help identify patients with breast, ovarian, pancreatic or prostate cancer who may benefit from targeted therapies ROCHESTER, Minn. — Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer […]